Metropolitan Life Insurance CO Medpace Holdings, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

55 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$174.31 - $239.52 $32,770 - $45,029
-188 Reduced 12.06%
1,371 $257,000
Q4 2022

Jun 14, 2023
BUY
$153.06 - $226.57 $28,775 - $42,595
188 Added 13.71%
1,559 $331 Million
Q4 2022

Mar 30, 2023
BUY
$153.06 - $226.57 $5,204 - $7,703
34 Added 2.23%
1,559 $331,000
Q4 2022

Feb 15, 2023
BUY
$153.06 - $226.57 $5,204 - $7,703
34 Added 2.23%
1,559 $331,000
Q3 2022

Jun 14, 2023
BUY
$145.13 - $182.49 $22,350 - $28,103
154 Added 11.23%
1,525 $240 Million
Q3 2022

Mar 30, 2023
SELL
$145.13 - $182.49 $19,737 - $24,818
-136 Reduced 8.19%
1,525 $239,000
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $19,737 - $24,818
-136 Reduced 8.19%
1,525 $240,000
Q2 2022

Jun 20, 2023
BUY
$130.2 - $168.03 $37,758 - $48,728
290 Added 21.15%
1,661 $248,000
Q2 2022

Mar 30, 2023
SELL
$130.2 - $168.03 $20,701 - $26,716
-159 Reduced 8.74%
1,661 $248,000
Q2 2022

Aug 11, 2022
SELL
$130.2 - $168.03 $20,701 - $26,716
-159 Reduced 8.74%
1,661 $249,000
Q1 2022

Jun 20, 2023
BUY
$138.87 - $214.31 $62,352 - $96,225
449 Added 32.75%
1,820 $297,000
Q1 2022

Mar 30, 2023
SELL
$138.87 - $214.31 $1.41 Million - $2.17 Million
-10,126 Reduced 84.76%
1,820 $297,000
Q1 2022

May 12, 2022
SELL
$138.87 - $214.31 $1.41 Million - $2.17 Million
-10,126 Reduced 84.76%
1,820 $298,000
Q4 2021

Jun 21, 2023
BUY
$182.74 - $227.9 $1.93 Million - $2.41 Million
10,575 Added 771.33%
11,946 $2.6 Million
Q4 2021

Mar 30, 2023
SELL
$182.74 - $227.9 $55,735 - $69,509
-305 Reduced 2.49%
11,946 $2.6 Million
Q4 2021

Feb 15, 2022
SELL
$182.74 - $227.9 $55,735 - $69,509
-305 Reduced 2.49%
11,946 $2.6 Million
Q3 2021

Jun 21, 2023
BUY
$170.18 - $198.21 $1.85 Million - $2.16 Million
10,880 Added 793.58%
12,251 $2.32 Million
Q3 2021

Mar 30, 2023
SELL
$170.18 - $198.21 $74,368 - $86,617
-437 Reduced 3.44%
12,251 $2.32 Million
Q3 2021

Nov 15, 2021
SELL
$170.18 - $198.21 $74,368 - $86,617
-437 Reduced 3.44%
12,251 $2.32 Million
Q2 2021

Jun 21, 2023
BUY
$158.62 - $194.3 $1.8 Million - $2.2 Million
11,317 Added 825.46%
12,688 $2.24 Million
Q2 2021

Mar 30, 2023
BUY
$158.62 - $194.3 $80,896 - $99,093
510 Added 4.19%
12,688 $2.24 Million
Q2 2021

Aug 16, 2021
BUY
$158.62 - $194.3 $2.01 Million - $2.46 Million
12,676 Added 105633.33%
12,688 $2.24 Million
Q1 2021

Jun 26, 2023
BUY
$132.02 - $168.26 $1.43 Million - $1.82 Million
10,807 Added 788.26%
12,178 $2 Billion
Q1 2021

Mar 30, 2023
SELL
$132.02 - $168.26 $10,033 - $12,787
-76 Reduced 0.62%
12,178 $2 Million
Q1 2021

May 14, 2021
SELL
$132.02 - $168.26 $1.62 Million - $2.06 Million
-12,242 Reduced 99.9%
12 $2 Million
Q4 2020

Jun 22, 2023
BUY
$109.38 - $149.19 $1.19 Million - $1.62 Million
10,883 Added 793.8%
12,254 $1.71 Million
Q4 2020

Mar 30, 2023
SELL
$109.38 - $149.19 $7,547 - $10,294
-69 Reduced 0.56%
12,254 $1.71 Million
Q4 2020

Feb 16, 2021
SELL
$109.38 - $149.19 $7,547 - $10,294
-69 Reduced 0.56%
12,254 $1.71 Million
Q3 2020

Jun 26, 2023
BUY
$92.95 - $130.61 $1.02 Million - $1.43 Million
10,952 Added 798.83%
12,323 $1.38 Million
Q3 2020

Mar 30, 2023
BUY
$92.95 - $130.61 $368,360 - $517,607
3,963 Added 47.4%
12,323 $1.38 Million
Q3 2020

Nov 13, 2020
BUY
$92.95 - $130.61 $368,360 - $517,607
3,963 Added 47.4%
12,323 $1.38 Million
Q2 2020

Jun 26, 2023
BUY
$68.08 - $95.68 $475,811 - $668,707
6,989 Added 509.77%
8,360 $777,000
Q2 2020

Mar 30, 2023
SELL
$68.08 - $95.68 $136 - $191
-2 Reduced 0.02%
8,360 $777,000
Q2 2020

Aug 14, 2020
SELL
$68.08 - $95.68 $136 - $191
-2 Reduced 0.02%
8,360 $778,000
Q1 2020

Jul 12, 2023
BUY
$61.71 - $101.95 $440,115 - $727,107
7,132 Added 520.2%
8,503 $623,000
Q1 2020

Mar 30, 2023
SELL
$61.71 - $101.95 $33,014 - $54,543
-535 Reduced 6.01%
8,362 $613,000
Q1 2020

May 15, 2020
SELL
$61.71 - $101.95 $33,014 - $54,543
-535 Reduced 6.01%
8,362 $614,000
Q4 2019

Jul 12, 2023
BUY
$70.08 - $84.64 $527,422 - $637,000
7,526 Added 548.94%
8,897 $747,000
Q4 2019

Mar 30, 2023
SELL
$70.08 - $84.64 $12,404 - $14,981
-177 Reduced 1.95%
8,897 $747,000
Q4 2019

Feb 14, 2020
SELL
$70.08 - $84.64 $12,404 - $14,981
-177 Reduced 1.95%
8,897 $748,000
Q3 2019

Jul 12, 2023
BUY
$62.38 - $85.89 $480,513 - $661,610
7,703 Added 561.85%
9,074 $762,000
Q3 2019

Mar 30, 2023
BUY
$62.38 - $85.89 $121,204 - $166,884
1,943 Added 27.25%
9,074 $762,000
Q3 2019

Nov 14, 2019
BUY
$62.38 - $85.89 $121,204 - $166,884
1,943 Added 27.25%
9,074 $763,000
Q2 2019

Jul 12, 2023
BUY
$53.64 - $65.42 $331,334 - $404,099
6,177 Added 450.55%
7,548 $493,000
Q1 2019

Jul 13, 2023
BUY
$49.38 - $70.58 $284,428 - $406,540
5,760 Added 420.13%
7,131 $420,000
Q1 2019

Mar 30, 2023
BUY
$49.38 - $70.58 $275,145 - $393,271
5,572 Added 357.41%
7,131 $420,000
Q1 2019

May 16, 2019
SELL
$49.38 - $70.58 $140,979 - $201,505
-2,855 Reduced 28.59%
7,131 $420,000
Q1 2019

May 15, 2019
BUY
$49.38 - $70.58 $140,979 - $201,505
2,855 Added 40.04%
9,986 $88,000
Q4 2018

Jul 13, 2023
BUY
$46.97 - $63.98 $270,547 - $368,524
5,760 Added 420.13%
7,131 $377,000
Q4 2018

Feb 14, 2019
BUY
$46.97 - $63.98 $261,575 - $356,304
5,569 Added 356.53%
7,131 $377,000
Q3 2018

Jul 13, 2023
BUY
$43.25 - $63.74 $249,120 - $367,142
5,760 Added 420.13%
7,131 $427 Million
Q3 2018

Nov 14, 2018
SELL
$43.25 - $63.74 $111,671 - $164,576
-2,582 Reduced 62.31%
1,562 $94,000
Q2 2018

Aug 15, 2018
BUY
$34.03 - $45.46 $51,283 - $68,508
1,507 Added 57.15%
4,144 $0
Q4 2017

Feb 15, 2018
SELL
$32.46 - $38.31 $91,861 - $108,417
-2,830 Reduced 51.77%
2,637 $96,000
Q3 2017

Nov 14, 2017
BUY
$27.43 - $33.11 $149,959 - $181,012
5,467
5,467 $174,000

Others Institutions Holding MEDP

# of Institutions
621
Shares Held
24.9M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email